Home / Tag Archives: insulin affordability

Tag Archives: insulin affordability

Human vs. Analogue Insulin: Does Newer Really Mean Better for Type 1 Diabetes?

Human insulin and analogue insulin options used in Type 1 diabetes treatment

The choice of human vs analogue insulin is especially important for people with Type 1 diabetes who live where healthcare resources are limited. Analogue insulins are often preferred because their action can be more predictable and flexible. However, human insulin is generally less expensive and may be easier for health …

Read More »

What Really Happens When Patients Stop Insulin Without Telling Their Doctor?

Patient with diabetes sitting at a table with insulin supplies and glucose monitoring equipment, illustrating the risks of stopping insulin therapy without medical supervision.

For many people living with diabetes, insulin is more than a medication—it is a lifeline. Yet despite its critical role, some patients stop taking insulin without informing their healthcare provider. The reasons vary widely and may include medication costs, treatment fatigue, fear of side effects, weight gain concerns, or misunderstandings …

Read More »

The FDA’s New Insulin Switching Rules: What Interchangeable Biosimilars Mean for Diabetes Care

Insulin pens beside an FDA symbol and prescription form representing interchangeable insulin biosimilars and pharmacy-level insulin switching in diabetes care.

A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …

Read More »